Literature DB >> 17848794

Silent celiac disease is frequent in the siblings of newly diagnosed celiac patients.

Maria Teresa Bardella1, Luca Elli, Pietro Velio, Clara Fredella, Luigia Prampolini, Bruno Cesana.   

Abstract

BACKGROUND/AIMS: Celiac disease is caused by environmental and genetic factors, and the relatives of celiac patients are at higher risk of developing celiac disease than the general population. This prospective study evaluates the prevalence of celiac disease in the asymptomatic siblings of celiac patients.
METHODS: Forty-eight siblings (22 males; mean age 13 years) of 39 celiac children (20 males; mean age 4 years), and 120 siblings (55 males; mean age 33 years) of 55 adult celiac patients (12 males; mean age 31 years) were serologically screened for celiac disease. Positive cases were considered for endoscopic duodenal biopsies.
RESULTS: Forty of the 168 asymptomatic siblings (23.8%) were affected by celiac disease. There were no differences between the index cases with and without affected siblings in terms of age at diagnosis, symptoms at onset, order of birth, associated disorders or other affected relatives. The male siblings of pediatric patients were affected in 40.9% of cases and female siblings in 26.9%; the corresponding figures for adults were 16.4 and 23.1%.
CONCLUSIONS: Silent celiac disease is 24-48 times more frequent in the siblings of celiac patients than in the general population. No predictive factors for sibling involvement were found. Adult females seem to tolerate gluten less than adult males. (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17848794     DOI: 10.1159/000107979

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

Review 1.  Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity.

Authors:  Luca Elli; Federica Branchi; Carolina Tomba; Danilo Villalta; Lorenzo Norsa; Francesca Ferretti; Leda Roncoroni; Maria Teresa Bardella
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Immunological comorbity in coeliac disease: associations, risk factors and clinical implications.

Authors:  Luca Elli; Antonella Bonura; Daniela Garavaglia; Eliana Rulli; Irene Floriani; Giovanna Tagliabue; Paolo Contiero; Maria Teresa Bardella
Journal:  J Clin Immunol       Date:  2012-04-19       Impact factor: 8.317

3.  Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.

Authors:  Nastaran Asri; Mohammad Rostami-Nejad; Abdolrahim Nikzamir; Elham Aghamohamadi; Hamid Asadzadeh-Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.742

Review 4.  Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis.

Authors:  Prashant Singh; Shubhangi Arora; Suman Lal; Tor A Strand; Govind K Makharia
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

5.  Hepatic hemangioma in celiac patients: data from a large consecutive series.

Authors:  Sara Massironi; Federica Branchi; Roberta Elisa Rossi; Mirella Fraquelli; Luca Elli; Maria Teresa Bardella; Federica Cavalcoli; Dario Conte
Journal:  Gastroenterol Res Pract       Date:  2015-01-12       Impact factor: 2.260

6.  Efficacy of a High-Iron Dietary Intervention in Women with Celiac Disease and Iron Deficiency without Anemia: A Clinical Trial.

Authors:  Alice Scricciolo; Luca Elli; Luisa Doneda; Karla A Bascunan; Federica Branchi; Francesca Ferretti; Maurizio Vecchi; Leda Roncoroni
Journal:  Nutrients       Date:  2020-07-17       Impact factor: 5.717

7.  A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet.

Authors:  Leda Roncoroni; Luca Elli; Luisa Doneda; Karla A Bascuñán; Maurizio Vecchi; Federico Morreale; Alice Scricciolo; Vincenza Lombardo; Nicoletta Pellegrini
Journal:  Nutrients       Date:  2018-11-15       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.